CYBR CyberCare the new look of healthcare Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare

CYBR 437.92

-1.1%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mama Bear who wrote (2266)	6/19/2000 7:18:00 PM
From: Tadsamillionaire	Read Replies (2) of 3392

Back to the facts.... CYBR owns the patent. They will receive license fees .....income regardless of who markets the product. Since CYBR plans to continue operations and sales, marketing the EHC, and other med tech devices from Georgia Tech. (They will own patents on these also, allowing more cash to be generated.)Doesnt it stand to reason that the company will be in the forefront of the industry? Now that FDA approval is on the EHC, IMHO, the company can and will go forward. WHY WOULD NORTEL GET INTO BED WITH CYBER CARE if there were questions regarding the patent. I trust NORTEL's due diligence more than Herb Greenburg's column. I am staying long on CYBR.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next